ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M05BA07 | G | Risedronate sodium - 150mg | 7576 | 185986/13 | APO-RISEDRONATE | 150mg | 1 | Tablet | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 1,034,759 L.L | 23.08 | A2 | Apotex Inc | Canada | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M05BA07 | G | Risedronate sodium - 150mg | 8785 | 88616/1 | PMS-RISEDRONATE | 150mg | 1 | Tablet | Oral | UPO S.A.L. | Pharmascience Inc | Canada | 806,306 L.L | 23.08 | A2 | Pharmascience Inc | Canada | 2/5/2024 | 0 |